The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of AZD4547 in FGFR amplified tumours: Gastroesophageal cancer (GC) cohort pharmacodynamic and biomarker results.
 
Elizabeth Catherine Smyth
No Relationships to Disclose
 
Nicholas C. Turner
Consulting or Advisory Role - SERVIER
Research Funding - AstraZeneca (Inst)
 
Alex Pearson
No Relationships to Disclose
 
Clare Peckitt
Consulting or Advisory Role - Sanofi
 
Ian Chau
Honoraria - Taiho Pharmaceutical
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Merck Serono; Sanofi
Research Funding - Merck Serono (Inst); Novartis (Inst); Roche Pharma AG (Inst); Sanofi (Inst)
 
David J. Watkins
Consulting or Advisory Role - Sanofi
 
Naureen Starling
No Relationships to Disclose
 
Sheela Rao
Honoraria - Lilly
Consulting or Advisory Role - Amgen; Celgene; Merck KGaA; Roche
 
Angela Gillbanks
No Relationships to Disclose
 
Elaine Kilgour
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Katherine Anne Sumpter
No Relationships to Disclose
 
Neil R. Smith
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Ros Cutts
No Relationships to Disclose
 
Claire Rooney
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Anne L. Thomas
Honoraria - Lilly; Roche Pharma AG
Consulting or Advisory Role - Lilly; Roche Pharma AG
 
Mazhar A. Ajaz
No Relationships to Disclose
 
Sue Chua
No Relationships to Disclose
 
Gina Brown
No Relationships to Disclose
 
Sanjay Popat
Research Funding - Boehringer Ingelheim (Inst)
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)